Genetic markers may help predict response to TNF inhibitor therapy in rheumatoid arthritis, potentially leading to more ...

TNF-inhibitors have several different safety issues than rituximab, tocilizumab and anakinra, and these distinctions may be important for certain RA patients. The risk/benefit ratio for the ...

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase ...

The first type of biologic approved for use in treating RA was designed to target the protein called TNF. These drugs are called anti-TNF biologics, and they block specific steps in the ...

An oral inhibitor would not only have delivery advantages over TNF-α inhibitors ... for much of the bone destruction in rheumatoid arthritis. “It seems like it affects all the partners that ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

A new study published recently in the journal Gut shows children with Crohn's who were prescribed anti-TNF (tumor necrosis factor) drugs following their diagnosis had an 82% lower risk of anal ...

Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 years, led by AbbVie’s blockbuster anti-TNF inhibitor treatment Humira (adalimumab).

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new study shows.

In Kids with Crohn's Disease, TNF Inhibitors Help Prevent Serious Complications, Data Suggests By Dennis Thompson HealthDay Reporter FRIDAY, Dec. 27, 2024 (HealthDay News) A specific class of anti ...